These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 1160431)

  • 1. [Preparation and evaluation of botulinum type A,B and E polyanatoxin combined with cholera vaccine. I. Preparation].
    Brühl A; Sochańska R
    Med Dosw Mikrobiol; 1975; 27(3):245-54. PubMed ID: 1160431
    [No Abstract]   [Full Text] [Related]  

  • 2. [Preparation and evaluation of botulinum type A, B and E polytoxoid combined with cholera vaccine. III. Human vaccination reactions and serological response].
    Galazka A; Rymkiewicz D; Switalska A; Trembowler P
    Med Dosw Mikrobiol; 1975; 27(3):265-80. PubMed ID: 1160433
    [No Abstract]   [Full Text] [Related]  

  • 3. [Preparation and evaluation of botulinum type A, B and E polytoxoid combined with cholera vaccine. II. Laboratory tests for safety and efficacy].
    Rymkiewicz D; Switalska A; Trembowler P
    Med Dosw Mikrobiol; 1975; 27(3):255-63. PubMed ID: 1160432
    [No Abstract]   [Full Text] [Related]  

  • 4. Botulinum antitoxins and antibacterial IgM and IgG antibodies in sera of persons immunized with botulinum polytoxoid combined with cholera vaccine. I. Response to botulinum toxoid.
    Galazka A; Rymkiewicz D; Aleksandrowicz J
    Arch Immunol Ther Exp (Warsz); 1976; 24(5):631-9. PubMed ID: 793566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum antitoxins and antibacterial IgM and IgG antibodies in sera of persons immunized with botulinum polytoxoid combined with cholera vaccine. II. Response to cholera vaccine.
    Galazka A; Rymkiewicz D; Aleksandrowicz J
    Arch Immunol Ther Exp (Warsz); 1976; 24(5):641-54. PubMed ID: 999475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulism among penned pheasants and protection by vaccination with C1 toxoid.
    Kurazono H; Shimozawa K; Sakaguchi G; Takahashi M; Shimizu T; Kondo H
    Res Vet Sci; 1985 Jan; 38(1):104-8. PubMed ID: 3883454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Study of New Tetravalent (Type A, B, E, and F) Botulinum Toxoid Vaccine Derived from M Toxin in Japan.
    Torii Y; Sugimoto N; Kohda T; Kozaki S; Morokuma K; Horikawa Y; Ginnaga A; Yamamoto A; Takahashi M
    Jpn J Infect Dis; 2017 Jul; 70(4):423-429. PubMed ID: 28250257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of a purified antigenic cholera toxoid.
    Germanier R; Fürer E; Varallyay S; Inderbitzin TM
    Infect Immun; 1976 Jun; 13(6):1692-8. PubMed ID: 823107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Gel filtration as a method of obtaining molecularly homogeneous bacterial toxins and anatoxins (a review of the literature)].
    Golshmid VK
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Dec; (12):89-96. PubMed ID: 4616559
    [No Abstract]   [Full Text] [Related]  

  • 10. Purification of bacterial exotoxins. The case of botulinum, tetanus, anthrax, pertussis and cholera toxins.
    Pasechnik VA; Shone CC; Hambleton P
    Bioseparation; 1992-1993; 3(5):267-83. PubMed ID: 1369426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulism and vaccines for its prevention.
    Smith LA
    Vaccine; 2009 Nov; 27 Suppl 4():D33-9. PubMed ID: 19837283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Value of the immunofluorescence test in the diagnosis of botulinum toxin poisoning in humans and animals. I. Identification of Clostridium botulinum type A, B, E, F and C in artificially infected industrial preserves by the indirect and direct immunofluorescence test].
    Anusz Z; Mierzejewski J; Skoczek A
    Przegl Epidemiol; 1973; 27(2):173-81. PubMed ID: 4578517
    [No Abstract]   [Full Text] [Related]  

  • 13. Cattle immune response to botulinum type D toxoid: results of a vaccination study.
    Steinman A; Galon N; Arazi A; Bar-Giora Y; Shpigel NY
    Vaccine; 2007 Nov; 25(44):7636-40. PubMed ID: 17913314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress toward development of an inhalation vaccine against botulinum toxin.
    Park JB; Simpson LL
    Expert Rev Vaccines; 2004 Aug; 3(4):477-87. PubMed ID: 15270652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative analysis of levels of serum immunoglobulin G against botulinum neurotoxin type D and association with protection in natural outbreaks of cattle botulism.
    Steinman A; Chaffer M; Elad D; Shpigel NY
    Clin Vaccine Immunol; 2006 Aug; 13(8):862-8. PubMed ID: 16893985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immunization of broiler chickens against type C botulism.
    Dohms JE; Allen PH; Cloud SS
    Avian Dis; 1982; 26(2):340-5. PubMed ID: 7049149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Toxoids of botulinum toxin type G].
    Puig de Centorbi ON; Ciccarelli AS; Giménez DF
    Rev Argent Microbiol; 1980; 12(1):10-7. PubMed ID: 6755549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Development of new generation of vaccine against pertussis, cholera, botulism, tetanus, and diphtheria toxins].
    Ivanov KK
    Mol Gen Mikrobiol Virusol; 1993; (2):3-9. PubMed ID: 8515748
    [No Abstract]   [Full Text] [Related]  

  • 19. Toxic proteins produced by Clostridium botulinum.
    Schantz EJ; Sugiyama H
    J Agric Food Chem; 1974; 22(1):26-30. PubMed ID: 4365698
    [No Abstract]   [Full Text] [Related]  

  • 20. Roads from vaccines to therapies.
    Smith LA; Jensen MJ; Montgomery VA; Brown DR; Ahmed SA; Smith TJ
    Mov Disord; 2004 Mar; 19 Suppl 8():S48-52. PubMed ID: 15027054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.